COPNCertificate of Public Need (Virginia Commissioner of Health)
COPNCognitive Optimization and Prediction (neuroscience)
COPNCentral Ohio Peace Network
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
LEWISGALE'S INITIAL APPLICATION for a COPN license called for a $3.4 million project that would have included an eight-bed neonatal specialty care unit, or NICU.
Suggestions were to look at the COPN process to unclog the system by overcoming the difficulty in opening new beds and units around the state, and particularly, to look at the state's needs and not just a localities [sic] need before determining to not allow additional beds to be opened."
In this case the module's COPN model contains equivalence relation between a unit/product and its components--a set of elements/units (Cyklis et al., 2005).
In the paper, Coloured Object Observable Petri Net (COPN) is chosen as a modelling tool.
17 February 2010 - Italy-based and Swiss-listed pharmaceutical company BioXell SpA (VTX: BXLN) said yesterday it found candidates to acquire certain technology assets prior to the settlement of the public tender offer by local peer Cosmo Pharmaceuticals SpA (VTX: COPN).
9 February 2010 - Italy-based drug maker Cosmo Pharmaceuticals (SWF: COPN) said today it holds 94.773% of all shares of peer firm BioXell (SWF: BXLN) after the acceptance period expired on 8 February 2010.
In November 2009, BioXell and Italy-based and Swiss-listed Cosmo Pharmaceuticals SpA (VTX: COPN) entered into an agreement under which the latter agreed to launch public tender offer for all outstanding shares of BioXell.
8 January 2010 - Chris Tanner, CFO of Italy-based Cosmo Pharmaceuticals (SWF: COPN), is content with the business in 2009 despite the small drop of orders and the hesitant product development, Tanner told news agency AWP on Friday.
This sale is considered a technology transaction within the agreement between Bioxell and Italy-based peer Cosmo Pharmaceuticals (SWF: COPN), the firm said further.
11 December 2009 - Italy-based specialty pharma company Cosmo Pharmaceuticals SpA (SWF: COPN) announced today positive results in a phase II pilot study of its novel topical anti-androgen 1% cream, CB-03-01.
8 December 2009 - Italy-based Cosmo Pharmaceuticals (SWF: COPN) said today it published its public tender offer to acquire all outstanding shares of Italian biopharmaceutical firm BioXell (SWF: BXLN).